Allergan introduces See America initiative
Allergan PLC recently started See America, a new initiative to combat preventable blindness in the U.S. Read More »
Spartanburg County law enforcement receives 60 doses of opiate antidote
Spartanburg County will receive 60 Opiate Overdose Kits, valued at more than $6,000, from Smith Drug Co. Read More »
Former Walmart executive joins Amgen Board of Directors
Charles Holley Jr. has joined the Amgen Board of Directors as a member of the Audit Committee and the Corporate Responsibility and Compliance Committee. Read More »
Renova, Janssen team up to develop stresscopin
Renova Therapeutics Inc. recently entered an alliance with Janssen Pharmaceuticals Inc. for the development of new treatments for congestive heart failure and Type 2 diabetes. Read More »
Speakers for upcoming PDA conference announced
Five speakers to the Parenteral Drug Association Pharmaceutical Quality Metrics and Culture Conference have been named. Read More »
NASP creates app to facilitate member connectivity
The National Association of Specialty Pharmacy recently made a new app available for members only. Read More »
Intarcia's application for Type 2 diabetes treatment is accepted
The U.S. Food and Drug Administration has accepted Intarcia Therapeutics' New Drug Application for ITCA 650, which can be used to treat Type 2 diabetes. Read More »
Express Scripts successfully curbs 2016 drug costs
Nationwide mail-order pharmacy giant Express Scripts recently revealed successful limits to 2016 drug spending — yielding a 27 percent decrease over that of 2015 — from St. Louis as it released its annual Drug Trend Report. Read More »
Teva intends to market generic version of Victoza
Teva Pharmaceutical Industries Ltd., recently announced their intent to market a new drug in the U.S. Read More »
Acorda Therapeutics to present at upcoming conferences
Biotechnology company Acorda Therapeutics Inc., which is known for its work in neurological disorders, will present at two investor conferences this month. Read More »
Narcan available over the counter at Dallas, Houston Krogers
Kroger will sell Narcan nasal spray in its Dallas and Houston stores, without the need of a prescription. Read More »
Trump calls for reductions in pharmaceutical prices
President Trump recently met with pharmaceutical executives concerning the prices of drugs and the regulations surrounding them. Read More »
Taxpayer groups oppose changes to 'process by which drug prices are negotiated for Medicare Part D'
In a letter sent to the U.S. House of Representatives, leaders from Americans for Tax Reform, Citizens Against Government Waste, and the National Taxpayers Union, urged congressional members to "oppose any attempts to change the successful and cost-saving process by which drug prices are negotiated for Medicare Part D." Read More »
Walgreens, Rite Aid decrease sale price by $2 billion
Walgreens Boots Alliance and Rite Aid recently came to an agreement on a price reduction for the purchase of Rite Aid. Read More »
Digital Pharmacist forged from merger of two companies
Digital Pharmacist Inc. was launched Jan. 31 after the strategic merger of TeleManager Technologies Inc. and RxWiki Inc. Read More »
Xyzal Allergy approved for over-the-counter sales
Sanofi has received FDA approval of Xyzal Allergy 24HR, an over-the-counter option for those suffering with certain allergies. Read More »
UnitedAg to host annual meeting in March
Blue Shield of California and OptumRX will co-sponsor agricultural trade organization UnitedAg's 37th Annual Meeting and Conference in Napa, California, March 14-17. Read More »
MinuteClinic helps fill gap in women's health care
Access to affordable and dependable health care for women has become growing issue, and one facility says that it is prepared to play a big role in the solution in making women’s health care more accessible. Read More »
Former CMS head: PBMs driving down drug costs, 'price-fixing' won't work
As the Trump Administration and new Congress signal their intent to somehow deal with the issue of rising prescription drug prices, the notion of giving the federal government more power to negotiate drug prices in Medicare Part D has been suggested as one measure that might be implemented. Two leading experts this week, however, threw cold water on that proposal, noting that such negotiations already exist and serve to bring down drug costs. Read More »
FDA issues new naming guidance for biologics, biosimilars
The U.S. Food and Drug Administration released its final guidance on naming biologics and biosimilars. Read More »
Alerts Sign-up